• MIPOMERSEN chembl:CHEMBL2219536 Approved

    Alternate Names:

    MIPOMERSEN
    ISIS-301012
    MIPOMERSEN SODIUM
    chemidplus:1000120-98-8
    pubchem.compound:44564107
    chembl:CHEMBL2219536
    rxcui:1367839
    drugbank:05528

    Drug Info:

    Drug Categories oligodeoxyribonucleotides, antisense
    Drug Categories nucleic acids
    Drug Categories nucleic acid probes
    Drug Categories molecular probes
    Drug Categories dna, antisense
    Drug Categories dna
    Drug Categories antisense elements (genetics)
    FDA Approval not approved
    Drug Class antisense oligo
    Drug Indications anticholesterolaemic agent
    Drug Groups investigational
    Drug Categories apolipoprotein b-100 synthesis inhibitor
    Drug Categories compounds used in a research, industrial, or household setting
    Drug Categories decreased protein synthesis
    Drug Categories hepatotoxic agents
    Drug Categories hypolipidemic agents indicated for hyperlipidemia
    (1 More Sources)

    Publications:

  • Interaction Score: 1.49

    Interaction Types & Directionality:
    n/a

    Interaction Info:
    Trial Name ISIS 301012
    Novel drug target Novel Target

    PMIDs:
    None found


    Sources:
    TdgClinicalTrial

  • Interaction Score: 1.35

    Interaction Types & Directionality:
    n/a

    Interaction Info:

    PMIDs:
    None found


    Sources:
    PharmGKB